Holen Sie sich die Stockscreener-App
342.00
1.00%
-2.92
Schlusskurs vom Vortag:
$344.92
Offen:
$346.64
24-Stunden-Volumen:
96,649
Relative Volume:
0.14
Marktkapitalisierung:
$24.03B
Einnahmen:
$2.36B
Nettoeinkommen (Verlust:
$236.10M
KGV:
103.95
EPS:
3.29
Netto-Cashflow:
$382.50M
1W Leistung:
+2.13%
1M Leistung:
+19.86%
6M Leistung:
+25.25%
1J Leistung:
+65.21%
1-Tages-Spanne:
$340.61
$346.64
1-Wochen-Bereich:
$331.75
$350.00
52-Wochen-Spanne:
$204.02
$350.00
Insulet Corporation Stock (PODD) Company Profile
Firmenname
Insulet Corporation
Sektor
Branche
Telefon
978-600-7000
Adresse
100 NAGOG PARK, ACTON, MA
Vergleichen Sie PODD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
341.43 | 23.93B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
130.96 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.23 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
388.63 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.46 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.56 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Buy |
| 2025-05-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-08-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-07-28 | Eingeleitet | Wells Fargo | Overweight |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Eingeleitet | BofA/Merrill | Neutral |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-12-10 | Eingeleitet | CFRA | Sell |
| 2019-10-23 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-10-04 | Herabstufung | UBS | Buy → Neutral |
| 2019-10-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-06 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-04-20 | Eingeleitet | Berenberg | Buy |
| 2018-02-22 | Bestätigt | Barclays | Overweight |
| 2018-01-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Insulet Corporation Aktie (PODD) Neueste Nachrichten
Can Insulet Corporation deliver consistent EPS growthJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - khodrobank.com
How to escape a deep drawdown in Insulet CorporationWeekly Loss Report & Reliable Intraday Trade Plans - Newser
How to integrate Insulet Corporation into portfolio analysis toolsMarket Performance Report & Expert Approved Momentum Trade Ideas - Newser
What high frequency data says about Insulet CorporationDay Trade & Free Verified High Yield Trade Plans - Newser
Analyzing net buyer seller activity in Insulet CorporationDividend Hike & Expert-Curated Trade Recommendations - Newser
Can volume confirm reversal in Insulet CorporationAnalyst Upgrade & Safe Entry Zone Tips - Newser
How to build a custom watchlist for Insulet CorporationPortfolio Return Report & Low Volatility Stock Suggestions - Newser
Intraday pattern recognizer results for Insulet CorporationJuly 2025 Summary & Risk Controlled Daily Plans - Newser
How to recover losses in Insulet Corporation stockQuarterly Portfolio Report & Weekly High Conviction Ideas - Newser
Is Insulet Corporation’s growth already priced in2025 Top Decliners & AI Driven Stock Movement Reports - خودرو بانک
Is Insulet Corporation a top pick in the sectorCPI Data & Weekly Return Optimization Alerts - khodrobank.com
How high can Insulet Corporation stock goQuarterly Earnings Summary & High Yield Stock Recommendations - Newser
Earnings Miss: Does Insulet Corporation have pricing powerWeekly Trade Recap & Low Drawdown Momentum Trade Ideas - khodrobank.com
Using data tools to time your Insulet Corporation exit2025 Trade Ideas & Verified Short-Term Plans - Newser
Tools to monitor Insulet Corporation recovery probabilityJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser
Custom strategy builders for tracking Insulet CorporationWeekly Trade Review & Expert Verified Stock Movement Alerts - Newser
Insulet (NASDAQ:PODD) shareholders have earned a 11% CAGR over the last five years - Yahoo Finance
Regression analysis insights on Insulet Corporation performanceWeekly Trading Summary & Pattern Based Trade Signal System - Newser
Smart tools for monitoring Insulet Corporation’s price actionEarnings Miss & Verified Trade Idea Suggestions - Newser
A | Is Insulet Corporation forming a breakout pattern2025 Volatility Report & Capital Efficiency Focused Ideas - khodrobank.com
What MACD and RSI say about Insulet CorporationJuly 2025 Movers & Low Drawdown Momentum Ideas - Newser
Can Insulet Corporation reach all time highs this yearQuarterly Growth Report & Low Risk High Win Rate Stock Picks - khodrobank.com
Candlestick signals on Insulet Corporation stock todayStop Loss & Daily Stock Momentum Reports - Newser
Order flow analysis tools used on Insulet CorporationJuly 2025 Summary & Real-Time Market Sentiment Reports - Newser
Does Insulet Corporation have declining or rising EPSMarket Performance Summary & Weekly High Conviction Trade Ideas - خودرو بانک
Published on: 2025-09-01 20:55:57 - Newser
How to track smart money flows in Insulet CorporationJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
Is Insulet Corporation subject to activist investor interestMarket Growth Summary & Low Drawdown Momentum Ideas - khodrobank.com
What are Insulet Corporation’s technical support levelsJuly 2025 Movers & Daily Volume Surge Trade Alerts - khodrobank.com
Insulet’s SWOT analysis: patch pump pioneer’s stock faces growth hurdles - Investing.com
Can Insulet Corporation keep up with sector leadersBreakout Watch & Fast Entry and Exit Trade Plans - khodrobank.com
Technical analysis overview for Insulet Corporation stock2025 AllTime Highs & Detailed Earnings Play Strategies - Newser
Is Insulet Corporation showing signs of accumulationEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Why We're Not Concerned About Insulet Corporation's (NASDAQ:PODD) Share Price - 富途牛牛
Why Insulet Corporation stock attracts strong analyst attentionJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Developing predictive dashboards with Insulet Corporation dataPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - Newser
What the charts say about Insulet Corporation todayJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Insulet appoints new COO - MSN
Insulet Gains 77.2% in a Year: What's Driving the Rally? - MSN
Is Insulet Corporation reversing from oversold territoryJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Resistance Break Could Fuel Insulet Corporation Rally getLinesFromResByArray error: size == 0 - thegnnews.com
Is Insulet Corporation trending in predictive chart modelsJuly 2025 Closing Moves & Accurate Technical Buy Alerts - Newser
Insulet Corporation stock daily chart insightsDay Trade & Real-Time Stock Price Movement Reports - Newser
How Insulet’s (PODD) New Growth-Focused Leadership May Shape Its Innovation and Global Expansion Strategy - simplywall.st
Insulet Corporation recovery potential after sell offQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - Newser
Technical Charts Suggest Momentum Shift in Insulet Corporation getLinesFromResByArray error: size == 0 - thegnnews.com
Key resistance and support levels for Insulet CorporationJuly 2025 Recap & Long-Term Safe Investment Ideas - Newser
Finanzdaten der Insulet Corporation-Aktie (PODD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):